C4 THERAPEUTICS INC. - COMMON STOCK
5.3800
04-十月-24 14:59:56
15 分钟延时
股票
+0.0400
+0.75%
今日范围
5.1800 - 5.4800
ISIN
N/A
来源
NASDAQ
-
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
30 9月 2024 15:01:00 条件 Nasdaq GlobeNewswire
-
C4 Therapeutics Announces Delivery of Second Development Candidate to Biogen
10 9月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
08 9月 2024 17:05:00 条件 Nasdaq GlobeNewswire
-
C4 Therapeutics Appoints Veteran Biotechnology Leader Stephen Fawell, Ph.D. to Board of Directors
03 9月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
C4 Therapeutics to Participate in Upcoming September Investor Conferences
29 8月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
14 8月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
01 8月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
16 7月 2024 15:01:00 条件 Nasdaq GlobeNewswire
-
C4 Therapeutics to Participate in the Virtual UBS Targeted Protein Degradation Day
08 7月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
C4 Therapeutics Appoints Ron Cooper as Chairman of the Board of Directors
10 6月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
08 5月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
29 4月 2024 15:01:00 条件 Nasdaq GlobeNewswire
-
C4 Therapeutics to Participate in the Stifel 2024 Targeted Oncology Forum
09 4月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
05 3月 2024 15:30:00 条件 Nasdaq GlobeNewswire
-
04 3月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
22 2月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
09 1月 2024 15:01:00 条件 Nasdaq GlobeNewswire
-
C4 Therapeutics Announces Closing of $25 Million Equity Investment by Betta Pharmaceuticals
04 1月 2024 15:01:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >